Document is current
Any future updates will be listed below
-
Authors
Pi-Bansa, Sellase
Osei, Joseph Harold Nyarko
Joannides, Joannitta
Woode, Maame Esi
Agyemang, David
Elhassan, Elizabeth
Dadzie, Samuel Kweku
Appawu, Maxwell Alexander
Wilson, Michael David
Koudou, Benjamin Guibehi
de Souza, Dziedzom Komi
Utzinger, Jürg
Boakye, Daniel Adjei
-
Funding
Funding for this research was provided by:
Sightsavers International
Liverpool School of Tropical Medicine
- License Information
-
More Information
Article History
Received: 15 August 2018
Accepted: 5 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: Ethical approval for the study was given by the Noguchi Memorial Institute for Medical Research Institutional Review Board (Accra, Ghana; CPN 077/13-14) and the research commission of the Swiss Tropical and Public Health Institute (Basel, Switzerland; 122a). Verbal consent was obtained from CVCs for participation in the various mosquito sampling methods. Participation was voluntary and hence CVCs could withdraw anytime from the study. Albendazole and ivermectin were administered to CVCs before mosquito sampling commenced. Arrangement was also made with the community-based health planning and services (CHPS) in the various districts to provide treatment for CVCs who reported to their facilities and tested positive for malaria.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
